Search Results - "Poorbaugh, Josh"
-
1
COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine
Published in PloS one (09-09-2022)“…Background The humoral response to SARS-CoV-2 can provide immunity and prevent reinfection. However, less is known about how the diversity, magnitude, and…”
Get full text
Journal Article -
2
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
Published in Journal of translational medicine (18-03-2022)“…A thorough understanding of a patient's inflammatory response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is crucial to…”
Get full text
Journal Article -
3
Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression
Published in Frontiers in immunology (21-06-2023)“…IL-21 is a multifunctional cytokine linked with the pathophysiology of several autoimmune diseases, including type 1 diabetes. In this study, our aim was to…”
Get full text
Journal Article -
4
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
Published in Frontiers in immunology (09-12-2021)“…Neutralizing monoclonal antibodies (mAbs) to SARS-CoV-2 are clinically efficacious when administered early, decreasing hospitalization and mortality in…”
Get full text
Journal Article -
5
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients
Published in Journal of translational medicine (08-09-2022)“…Keywords: COVID-19, CXCL9, Cytokine, Dexamethasone, Inflammation, Serology…”
Get full text
Journal Article -
6
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754): A Phase I Randomized Placebo‐Controlled Study
Published in Clinical pharmacology and therapeutics (01-05-2024)“…For some patients with psoriasis, orally administered small molecule inhibitors of interleukin (IL)‐17A may represent a convenient alternative to…”
Get full text
Journal Article -
7
First‐in‐Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID‐19
Published in Clinical pharmacology and therapeutics (01-12-2021)“…Therapeutics for patients hospitalized with coronavirus disease 2019 (COVID‐19) are urgently needed during the pandemic. Bamlanivimab is a potent neutralizing…”
Get full text
Journal Article -
8
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination
Published in Science translational medicine (27-07-2022)“…As the coronavirus disease 2019 (COVID-19) pandemic evolves and vaccine rollout progresses, the availability and demand for monoclonal antibodies for the…”
Get more information
Journal Article -
9
Identification of Human T Cell Biomarkers: A Gene Signature for CD8 T Cell Exhaustion and Ultrasensitive Elisa Methods for Il-21
Published 01-01-2019“…CD8 T cell exhaustion is the progressive, step-wise loss of T cell function due to persistent antigen stimulation. Given the importance of this phenomenon in…”
Get full text
Dissertation -
10
Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies
Published in Journal of immunological methods (01-03-2019)“…IL-21 is a pleiotropic cytokine that plays a key role in modulating inflammatory responses, including the promotion of autoimmune diseases. Several groups have…”
Get full text
Journal Article -
11
146. Intact Sense of Taste and Smell During COVID-19 Infection Is Associated with Absence of of SARS-CoV-2 Spike Protein Antibody Responses within 3 Months of Symptomatic Illness
Published in Open forum infectious diseases (04-12-2021)“…Abstract Background Although studies show most COVID-19 survivors have post-infection immunity against SARS-CoV-2 that could prevent re-infection, there is…”
Get full text
Journal Article -
12
Level and Duration of IgG and Neutralizing Antibodies to SARS-CoV-2 in Children with Symptomatic or Asymptomatic SARS-CoV-2 Infection
Published in ImmunoHorizons (01-06-2022)“…Abstract There are conflicting data about level and duration of Abs to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children after…”
Get full text
Journal Article -
13
Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization – A case study
Published in Biologicals (01-11-2008)“…An adventitious agent contamination occurred during a routine 9 CFR bovine viral screening test at BioReliance for an Eli Lilly Chinese Hamster Ovary (CHO)…”
Get full text
Journal Article